Scopri le migliori cliniche e prezzi per il trattamento di Obesità in Italia 2026

Italy is the first country globally to legally recognize obesity as a chronic, progressive, and relapsing disease. Under Law No. 149/2025, the Italian Senate shifted obesity from a lifestyle choice to a pathology. This legislation integrates obesity treatment into the National Health Service (SSN) framework.

• Universal access: Obesity care is now part of the Essential Levels of Care (LEA).
• National funding: Italy allocated 1.2 million Euros annually starting in 2027 for treatment.
• Anti-stigma laws: The legislation mandates measures against weight-based discrimination in schools and workplaces.
• Medical training: Specific budgets fund specialized obesity management training for general practitioners and psychologists.

Bookimed Expert Insight: While the 2025 law sets a global legal precedent, clinical expertise in Italy was already highly developed. IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan performs over 5,000 operations annually. Surgeons like Dr. Alessandro Giovanelli have completed over 9,000 procedures. This high volume ensures that legal recognition is backed by significant surgical experience and advanced technology like the da Vinci robot.

Patient Consensus: Patients note that while the law provides a framework, actual access to surgery under the public system requires meeting strict BMI thresholds. It remains essential to document all previous weight-loss attempts and comorbidities meticulously for insurance or health service approval.

Eligibility for bariatric surgery via the Italian National Health System requires a Body Mass Index of 40 or higher. Patients with a Body Mass Index of 35 may qualify if they have serious comorbidities. These conditions include type 2 diabetes, hypertension, or severe obstructive sleep apnea.

• Age range: Usually available for adults aged 18 to 65 years.
• Documented attempts: Patients must prove 6 months of supervised, unsuccessful weight loss.
• Psychological clearance: Mandatory mental health evaluation ensures readiness for permanent lifestyle changes.
• Clinical stability: Underlying health conditions must be medically managed before surgical intervention.

Bookimed Expert Insight: Italian centers of excellence show a clear preference for high-volume expertise. For example, Dr. Alessandro Giovanelli at IRCCS Ospedale Galeazzi - Sant'Ambrogio has performed over 9,000 operations. Choosing a surgeon with this volume often leads to better access to advanced technologies like the da Vinci robot, which is available in Milan and Rome clinics.

Patient Consensus: Patients note that meeting the strict BMI requirements is only the first step. Many emphasize that keeping detailed logs of past diets and exercise is essential to avoid application rejections.

In Italy, the Italian Medicines Agency (AIFA) authorizes semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and orlistat (Xenical) for weight management. Doctors prescribe these for patients with a BMI over 30. Specialists at clinics like San Raffaele in Milan also utilize naltrexone/bupropion (Mysimba) for appetite control.

• Approved GLP-1 analogs: Wegovy and Saxenda are primary injectable options for chronic weight loss.
• Diabetes medications: Ozempic and Mounjaro are prescribed off-label for significant weight reduction benefits.
• Oral therapies: Orlistat prevents 25% fat absorption and remains a common first-line treatment.
• Prescription requirements: All medications require a formal prescription from a GP or specialist.

Bookimed Expert Insight: While many patients seek GLP-1 injections, Italian medical centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio often integrate these with surgical consultations. Data shows that high-volume centers performing over 5,000 operations annually prioritize long-term metabolic health. This suggests that medications are increasingly used as a bridge to, or in combination with, procedures like intragastric balloons, which may cost around $6,050 in specialized Milanese clinics.

Patient Consensus: Patients note that while Saxenda is widely available through GPs, newer drugs like Wegovy often face supply shortages. Many find that private endocrinologist visits in Milan or Rome provide faster access to prescriptions than the public health system.

To start obesity treatment in Italy, obtain a medical referral from a primary care physician to access the National Health Service (SSN) framework. Patients typically undergo multidisciplinary screenings at accredited centers. Specialized facilities like IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan offer advanced robotic and laparoscopic surgical interventions.

• Initial referral: Consult a family doctor to obtain an impegnativa for specialized obesity care.
• Specialized centers: Seek centers accredited by the Italian Obesity Society (SIO) for comprehensive pathways.
• Surgical eligibility: Bariatric surgery generally requires a BMI over 40 or 35 with complications.
• Robotic technology: High-volume hospitals in Milan and Rome utilize the da Vinci robotic system.

Bookimed Expert Insight: Italian centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio provide high-tier surgical safety with specialists like Dr. Alessandro Giovanelli performing over 9,000 operations. Our data shows that top Milanese clinics often bundle language assistance and 3-4 days of hospitalization into surgical packages. This level of institutional experience is vital for complex revisions, as this specific hospital performs 75% of Italy's orthopedic revisions, signaling a strong culture of managing difficult cases.

Patient Consensus: Patients note that while the public system is affordable, waiting times can exceed 6 months, leading many to choose private care in Northern Italy for faster access. Many suggest keeping detailed records of your BMI and past weight loss attempts to speed up the surgical approval process.

Italy hosts nationally recognized centers for obesity treatment, primarily concentrated in Milan and Lombardy. Leading institutions include IRCCS Policlinico San Donato and IRCCS Ospedale Galeazzi-Sant’Ambrogio. These facilities hold IRCCS accreditation from the Italian Ministry of Health for excellence in clinical research and specialized bariatric care.

• IRCCS Ospedale Galeazzi-Sant’Ambrogio: A Milan-based facility performing over 9,000 bariatric operations.
• Specialized surgical techniques: Surgeons utilize laparoscopic and da Vinci robotic technology for precision.
• San Raffaele Hospital: Provides advanced gastric bypass and sleeve procedures led by expert professors.
• Multidisciplinary care teams: Accredited centers integrate endocrinologists, nutritionists, and psychologists for treatment.

Bookimed Expert Insight: While hospital reputation is vital, our data shows a significant technology gap in mid-range packages. IRCCS Ospedale Galeazzi-Sant’Ambrogio offers robotic-assisted procedures for approximately $30,000, which is nearly $10,000 more than standard laparoscopic options. For patients with high BMI or previous abdominal surgeries, the robotic platform's precision may justify this investment to ensure smoother recovery.

Patient Consensus: Patients note that private care in Milan or Bologna significantly reduces waiting times compared to the 18-month national health service queues. Many recommend verifying if surgeons personally perform at least 100 cases annually to ensure the highest safety standards.

Italy hosts leading obesity centres accredited as Research Hospitals (IRCCS) by the Ministry of Health. Top facilities like San Donato and San Raffaele in Milan provide multidisciplinary bariatric surgery. These centres use laparoscopic and Da Vinci robotic systems for gastric sleeve and bypass procedures.

• University research status: IRCCS certification means the Italian Ministry of Health oversees research and care standards.
• Surgical options: Surgeons perform minimally invasive sleeve gastrectomies, gastric bypasses, and robotic-assisted metabolic operations.
• Expert surgical leads: Prof. Dr Riccardo Rosati at San Raffaele oversees approximately 2,000 surgical cases annually.
• Obesity society affiliation: Specialists like Dr Antonio Braun belong to the Italian Society of Obesity Surgery.

Bookimed Expert Insight: Milan serves as Italy's primary hub for complex metabolic surgery. Clinics like San Donato and Galeazzi–Sant'Ambrogio handle over 300,000 patients annually. This high volume allows surgeons to specialise in specific bariatric techniques. For example, Dr Antonio Braun at Maria Cecilia Hospital has performed over 12,000 gastrointestinal interventions. This level of experience often leads to more refined surgical outcomes for international patients.

Patient Consensus: Patients recommend choosing major Italian university hospitals with dedicated bariatric teams over small private clinics. They emphasise confirming that the centre provides a full pathway. This should include dietitians, psychologists, and clear plans for post-operative follow-up.

Wegovy and Ozempic are available in Italy. Wegovy launched for weight management in mid-2024. Ozempic is primarily used for Type 2 diabetes. Both require a private prescription from a doctor. Patients usually pay out-of-pocket for weight loss medications.

• Primary indications: Wegovy is for weight loss. Ozempic treats Type 2 diabetes.
• Prescription requirements: Doctors must provide a private prescription after a medical consultation.
• Clinical availability: Specialist centres like La Madonnina Clinic in Milan provide obesity consultations.
• Public coverage: The Italian National Health Service (SSN) typically does not cover these costs.

Bookimed Expert Insight: Italian obesity specialists often combine medications with diagnostic tests. IRCCS Ospedale Galeazzi - Sant'Ambrogio and San Raffaele use genetic screening and hormonal profiling. These tests help determine if Wegovy is the most effective choice for a patient's biological profile.

Patient Consensus: Patients in Italy note that Ozempic is hard to find for weight loss. It is strictly reserved for diabetes. Most recommend checking pharmacy stock for Wegovy before travel. Having a local medical consultation first is essential for obtaining a valid prescription.

Intragastric balloons are widely used in Italy as a non-surgical obesity treatment. Clinics in Milan and Rome offer these endoscopic procedures for temporary weight loss. Patients typically go home the same day. Specialists use balloons to bridge the gap between lifestyle changes and surgery.

• Clinical availability: Major centres like La Madonnina Clinic in Milan provide specialised obesity treatment programmes.
• Endoscopic procedure: Doctors insert the balloon through the mouth. No surgical incisions are required.
• Duration options: Italian clinics offer programmes lasting between 6 and 12 months for weight loss.
• Specialist expertise: Surgeons like Dr Antonio Braun have performed over 12,000 gastrointestinal interventions in Italy.

Bookimed Expert Insight: Italy is famous for bariatric surgery. Its research hospitals focus heavily on multidisciplinary care. San Raffaele in Milan treats 2,000 surgical cases annually in its gastrointestinal department. This high volume means surgeons are experts at managing complex digestive health. Australian patients should look for clinics with IRCCS accreditation. This signals a top-tier Italian research hospital.

Patient Consensus: Patients in Italy note that balloons help them feel full quickly. They also find it easier to reduce portion sizes. They mention that lasting results depend on dietary support and better habits after balloon removal.

The first step for non-surgical obesity treatment in Italy is a medical assessment lead by an endocrinologist. This exam identifies metabolic profiles and underlying health issues. Italian clinics use these results to build personalised lifestyle plans. They also evaluate if patients suit prescription medications.

• Multidisciplinary team: Cases involve nutritionists, dietitians, and psychologists for holistic weight management.
• Endocrinologic exam: Specialists perform blood tests for hormonal profiles and genetic screening.
• Lifestyle intervention: Clinics design customised nutritional plans paired with structured physical activity.
• Pharmacotherapy evaluation: Doctors may prescribe medications such as semaglutide or liraglutide for patients.

Bookimed Expert Insight: Italian obesity centres like IRCCS Ospedale Galeazzi - Sant'Ambrogio and La Madonnina Clinic specialise in this initial diagnostic phase. While many patients seek surgery, these clinics focus on IRCCS-accredited research standards. This ensures that non-surgical pathways are exhausted before considering invasive options. High-volume specialists like Prof. Riccardo Rosati at San Raffaele provide the clinical oversight necessary for such complex metabolic cases.

International patients access public bariatric surgery in Italy by establishing legal residency and enrolling in the National Health Service (SSN). Eligibility requires a BMI of 40, or 35 with comorbidities. A documented history of obesity exceeding 5 years and failed conservative treatments are mandatory.

• Residency registration: Obtain a tax code and Italian health insurance card via local health authorities.
• BMI standards: Minimum 40 kg/m² or 35 kg/m² with conditions like type 2 diabetes.
• Clinical assessment: Undergo mandatory psychological, nutritional, and surgical evaluations at SICOB-accredited public hospitals.
• GP referral: Select an Italian GP to provide the necessary surgical referral (impegnativa).

Bookimed Expert Insight: Italian bariatric surgery standards are shaped by research centres like San Raffaele and San Donato. Surgeons such as Dr Antonio Braun at Maria Cecilia Hospital bring expertise from institutions like Johns Hopkins University. Public pathways have long waiting lists. However, these specialised IC-accredited facilities maintain high surgical volumes and rigorous safety protocols.

Patient Consensus: Patients find administrative eligibility is the primary hurdle in Italy. This often requires residency before accessing public care. Verification of regional rules is essential. Individual bariatric units may require different documentation for multidisciplinary assessments.